Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

May 7, 2020 Leave a comment 1,652 Views

Bayer today announced the launch of Test4TRK™ program in collaboration with NeoGenomics, Inc. to offer genomic cancer testing for NTRK gene fusions at no cost for patients with RAI-refractory (RAI-R) differentiated thyroid carcinoma (DTC) and metastatic...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: NTRK

Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers

The Curated Cancer Cell Atlas – a comprehensive pan-cancer single-cell RNA-sequencing dataset

Single cell RNA-Seq and AI provide ‘crystal ball’ into leukaemia treatment-response

Unraveling the secrets of nerve regeneration: insights from RNA sequencing

New pan-cancer single-cell T cell atlas reveals new details of tumor microenvironment

scSemiAAE – a semi-supervised clustering model for single-cell RNA-seq data

Avidity Sequencing – high accuracy with low reagent consumption

scMEB – a fast and clustering-independent method for detecting differentially expressed genes in single-cell RNA-seq data